Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Male gender and family history predict alopecia areata recurrence.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Tofacitinib may help treat severe hair loss, but more research is needed.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Dermoscopy improves accuracy in predicting treatment success for androgenetic alopecia with the Regenera® protocol.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Vitamin D levels do not affect the risk of developing alopecia areata.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Certain gene variations may increase the risk and severity of alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Ruxolitinib can help regrow hair in severe alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Non-immune factors play a significant role in alopecia areata.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The visfatin GT genotype may increase the risk of Alopecia Areata.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

People with alopecia who are more resilient tend to feel less stressed.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.